US 12,102,445 B2
Monitoring and communicating information using drug administration devices
Frederick E. Shelton, IV, Hillsboro, OH (US); Monica A. Kapil, San Jose, CA (US); Emma L. Hubert, San Jose, CA (US); and Jason L. Harris, Lebanon, OH (US)
Assigned to Janssen Pharmaceuticals, Inc., Titusville, NJ (US)
Filed by Janssen Pharmaceuticals, Inc., Titusville, NJ (US)
Filed on Oct. 13, 2020, as Appl. No. 17/068,865.
Claims priority of provisional application 63/020,940, filed on May 6, 2020.
Claims priority of provisional application 63/020,925, filed on May 6, 2020.
Claims priority of provisional application 63/020,928, filed on May 6, 2020.
Prior Publication US 2021/0345953 A1, Nov. 11, 2021
Int. Cl. A61B 5/00 (2006.01); A61B 5/0205 (2006.01); A61B 5/11 (2006.01); A61B 5/145 (2006.01); A61M 5/172 (2006.01); A61M 5/20 (2006.01); A61M 15/00 (2006.01); A61M 15/08 (2006.01); G16H 10/60 (2018.01); G16H 20/10 (2018.01); G16H 20/30 (2018.01); G16H 20/40 (2018.01); G16H 20/60 (2018.01); G16H 40/20 (2018.01); G16H 40/40 (2018.01); G16H 40/67 (2018.01); G16H 50/30 (2018.01); G16H 70/40 (2018.01); H04W 12/02 (2009.01); H04W 12/0431 (2021.01); A61B 5/021 (2006.01); A61B 5/024 (2006.01)
CPC A61B 5/4839 (2013.01) [A61B 5/0022 (2013.01); A61B 5/02055 (2013.01); A61B 5/1101 (2013.01); A61B 5/1112 (2013.01); A61B 5/1118 (2013.01); A61B 5/14532 (2013.01); A61B 5/14542 (2013.01); A61B 5/4266 (2013.01); A61B 5/4866 (2013.01); A61M 5/1723 (2013.01); A61M 5/2033 (2013.01); A61M 15/0065 (2013.01); A61M 15/08 (2013.01); G16H 10/60 (2018.01); G16H 20/10 (2018.01); G16H 20/30 (2018.01); G16H 20/40 (2018.01); G16H 20/60 (2018.01); G16H 40/20 (2018.01); G16H 40/40 (2018.01); G16H 40/67 (2018.01); G16H 50/30 (2018.01); G16H 70/40 (2018.01); H04W 12/02 (2013.01); H04W 12/0431 (2021.01); A61B 5/021 (2013.01); A61B 5/024 (2013.01); A61B 2560/0242 (2013.01); A61M 2205/3317 (2013.01); A61M 2205/3327 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2205/505 (2013.01); A61M 2205/52 (2013.01); A61M 2230/04 (2013.01); A61M 2230/20 (2013.01); A61M 2230/201 (2013.01); A61M 2230/50 (2013.01); A61M 2230/63 (2013.01)] 15 Claims
OG exemplary drawing
 
1. A surgical system, comprising:
a surgical hub including a communications interface configured to wirelessly receive data during performance of a surgical procedure; and
a drug administration device configured to deliver a drug therefrom to a patient, the drug administration device including:
a sensor configured to sense information relating to a condition of the patient,
a memory configured to store data therein, the stored data including a key established with a surgical hub and that is unique to the drug administration device and the surgical hub,
a communications interface configured to wirelessly transmit data indicative of the sensed information to the communications interface of the surgical hub, and
a processor configured to use the key to anonymize the data indicative of the sensed information prior to the transmission of the data indicative of the sensed information.